ArticleWorld journal of gastroenterology2007
Bravo (wireless) ambulatory esophageal pH monitoring: how do day 1 and day 2 results compare?
Article in World journal of gastroenterology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 23 citations in OpenAlex.
- Unsedated peroral wireless pH capsule placement vs. standard pH testing: a randomized study and cost analysis.BMC gastroenterology · 2012Trial
- Trial
- Adoption of unsedated transoral wireless pH capsule at a Veterans Affairs hospital: a feasibility study.iGIE : innovation, investigation and insights · 2026Article
- Early cardia neoplasms in the upper gastrointestinal tract have a higher detection rate under sedation: a retrospective cohort study based on the Chinese population.Frontiers in medicine · 2026Article
- Effect of anesthesia on gastroesophageal reflux in children: a study using BRAVO wireless pH study measurements.Neurogastroenterology and motility · 2015Article
- Inconsistency in the Diagnosis of Functional Heartburn: Usefulness of Prolonged Wireless pH Monitoring in Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease.Journal of neurogastroenterology and motility · 2015Article
- Negative impact of sedation on esophagogastric junction evaluation during esophagogastroduodenoscopy.World journal of gastroenterology · 2014Article
- Esophagogastroduodenoscopy with conscious sedation does not interfere with catheter-based 24-h pH monitoring.World journal of gastroenterology · 2013Article
- Clinical utility and tolerability of JSPH-1 wireless esophageal pH monitoring system.BMC gastroenterology · 2013Article
- Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease.Surgical endoscopy · 2011Article
- Does deep sedation impact the results of 48 hours catheterless pH testing?World journal of gastroenterology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo investigate if differences exist for patients' gastroesophageal reflux as measured by the Bravo ambulatory esophageal pH system between d 1 and d 2.
methodsA retrospective study of 27 consecutive adult patients who underwent Bravo esophageal pH monitoring was performed. Patients underwent EGD under IV conscious sedation prior to Bravo placement. Acid reflux variables and symptom scores for d 1 were compared to d 2.
resultsThe mean doses of fentanyl and midazolam were 90.4 microg and 7.2 mg, respectively. D 1 results were significantly more elevated than d 2 with respect to total time pH < 4, upright position reflux, and mean number of long refluxes. No statistical difference was noted between the two days for supine position reflux, number of refluxes, duration of longest reflux, episodes of heartburn, and symptom score.
conclusionPatients undergoing Bravo esophageal pH monitoring in association with EGD and moderate conscious sedation experience significantly more acid reflux on d 1 compared to d 2. The IV sedation may be responsible for the increased reflux on d 1. Performed this way, 48-h Bravo results may not be entirely representative of the patients' true GE reflux profile.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.